Imperial College London
Clinical trials sponsored by Imperial College London, explained in plain language.
-
Eye implant for diabetes: a bold idea that never got off the ground
Disease control TerminatedThis study aimed to test the safety of placing insulin-producing cells into the front part of the eye for people with type 1 diabetes. Only 6 participants with severe vision loss in one eye were planned. The study was withdrawn before any participants were enrolled, so no results…
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New hope for rare cancer: drug combo shows promise in early trial
Disease control OngoingThis study tests a new treatment for people with advanced high-grade neuroendocrine tumors, a rare and aggressive cancer. The treatment combines chemotherapy with an immunotherapy drug, followed by two maintenance drugs to keep the cancer under control. The goal is to see if this…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Heart disease mystery: 2000 patients join quest for genetic clues
Knowledge-focused OngoingThis study follows 2000 people with dilated cardiomyopathy, a condition where the heart becomes enlarged and weak. Researchers collect blood for genetic testing and perform heart MRI scans to look for scarring. The goal is to find genetic changes and heart damage patterns that co…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC
-
Digital health study tests apps for healthy aging
Knowledge-focused OngoingThis study explores whether using smartphone apps and sensors can help adults aged 65 and older adopt healthier habits. Researchers will compare two different digital programs to a simple education leaflet. The goal is to see if a larger trial is possible and how well participant…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC
-
Healthy volunteers help unlock lung protein secrets for future treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis study involves 16 healthy volunteers aged 25-75 to understand how a drug called XBD173 binds to a protein (TSPO) in the lungs. Researchers use PET scans to measure binding at different doses and with or without food. The goal is to gather knowledge needed to design future st…
Phase: NA • Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC